Actively Recruiting

Phase Not Applicable
Age: 19Years +
All Genders
NCT05806346

Goal-directed vs. Empirical Tranexamic Acid Administrationin Cardiovascular Surgery

Led by Konkuk University Medical Center · Updated on 2024-12-18

764

Participants Needed

3

Research Sites

99 weeks

Total Duration

On this page

Sponsors

K

Konkuk University Medical Center

Lead Sponsor

K

Korea Health Industry Development Institute

Collaborating Sponsor

AI-Summary

What this Trial Is About

The present study is a multi-center randomized prospective placebo-controlled non-inferiority trial. The study's primary objective is to compare the amounts of postoperative bleeding using two different TXA administration strategies: empirical TXA administration vs. viscoelastic test-based goal-directed TXA administration in cardiovascular surgery. The secondary objectives include comparing the incidents of hyper-fibrinolysis, thromboembolic complications, and postoperative seizures. Researchers assumed that goal-directed tranexamic acid (TXA) administration using viscoelastic field tests would not be inferior to the empirical TXA administration strategy in reducing postoperative bleeding and hyper-fibrinolysis. It also would be beneficial in lowering TXA-induced thromboembolic complications and seizures.

CONDITIONS

Official Title

Goal-directed vs. Empirical Tranexamic Acid Administrationin Cardiovascular Surgery

Who Can Participate

Age: 19Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients who will undergo elective cardiovascular surgery employing cardiopulmonary bypass
  • Patients who provide written informed consent
Not Eligible

You will not qualify if you...

  • Pregnancy
  • Refusal of allogenic blood transfusion
  • Taking thrombin
  • History of thromboembolic and familial hypercoagulability disease
  • Recent history of myocardial infarction or ischemic cerebral infarction (within 90 days)
  • Hypersensitive to TXA
  • History of convulsion or epilepsy
  • Taking hemodialysis
  • History of Heparin-induced thrombocytopenia

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 3 locations

1

Konkuk University Medical Center

Seoul, South Korea, 05030

Actively Recruiting

2

Samsung Medical Center

Seoul, South Korea, 06351

Actively Recruiting

3

Asan Medical Center

Seoul, South Korea

Actively Recruiting

Loading map...

Research Team

T

Tae-Yop Kim, MD PhD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

QUADRUPLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

DIAGNOSTIC

Number of Arms

4

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here